QUIGLEY CEO, TED KARKUS, ANNOUNCES PHASE ONE OF 2010 STRATEGIC PLAN
QUIGLEY CORPORATION ANNOUNCES FINAL RESULTS OF QUIGLEY PHARMA'S PHASE IIB STUDY
TED KARKUS NAMED CEO OF THE QUIGLEY CORPORATION
More +
Enter Quigley Pharma. With a growing pipeline, the Company is developing numerous compounds to address several major health issues facing the world today.
+ More
SEC Filing
Download 2008 Annual Report
![[rANDd_module_callout.jpg]](http://www.quigleypharma.com/uploads/images/rANDd_module_callout.jpg "[rANDd_module_callout.jpg]")
![[home_module_foot.gif]](http://www.quigleypharma.com/uploads/images/home_module_foot.gif "[home_module_foot.gif]"){kind=small}
![[Qlogo.gif]](http://www.quigleypharma.com/uploads/images/Qlogo.gif "[Qlogo.gif]")